Market Open

Tel Aviv Stock Exchange (TASE) Mixed: Which Stock Is Plunging About 34%?

An electronic board displaying market data at the Tel Aviv Stock Exchange in Tel Aviv, April 30, 2026. Photo by Miriam Alster/Flash90 *** Local Caption *** Stock exchange securities exchange Tel Aviv Stock Exchange economy Israel trading indexes trading data capital market Israeli capital market stock market Tel Aviv war Iran Israel
The Tel Aviv Stock Exchange | Photo: Miriam Alster/Flash90

Today (Wednesday), the market opened mixed, with the TA-35 down about 0.69%, the TA-90 up about 0.12%, and the TA-125 down about 0.48%.

In addition, the Poalim Resilience index is losing about 1.03%, while the TA-Technology index is down about 0.99%. By contrast, the TA-Energy Infrastructure index is up about 1.53%.

Declines are led by Bonus BioGroup, which is plunging about 34.64%, followed by Camtek, which is tumbling about 15.63%, and OPKO Health, which is losing about 5.31%.

Furthermore, NewMed Energy reported today that the notice canceling the agreement to supply natural gas from the Leviathan reservoir remains in effect. According to the company, the agreement was canceled because the conditions precedent stipulated in it were not met.

Camtek, illustration
Camtek, illustration | Photo: Shutterstock

By contrast, Dalia claims that the agreement has already taken effect. The company notified Ratio and the partnership yesterday that, in its view, the cancellation notice they issued is invalid.

The dispute between the parties concerns an agreement to supply natural gas from the Leviathan reservoir. Ratio and the partnership claim that the conditions stipulated for completing the transaction were not met and that the agreement was therefore canceled, while Dalia claims that the agreement took effect and that the cancellation notice is invalid.

Three partners hold stakes in the Leviathan reservoir: the partnership holds 45.34%, Chevron Mediterranean Limited holds 39.66%, and Ratio Energies holds 15%.

Gains are led by Givui Holdings, which is jumping about 28.57%, followed by BioView, which is soaring about 12.54%. Finally, Levinthal shares are climbing about 6.79%.

In addition, Doral reported today that its project companies in the U.S. signed three agreements to purchase solar panels from an international supplier at a total cost of about $470 million. The panels are intended for three projects with a combined capacity of about 1.45 gigawatts.

Tel Aviv Stock Exchange (TASE)
Tel Aviv Stock Exchange (TASE) | Photo: Adam Shuldman, Flash90

The three projects are part of the company’s mature project pipeline and are at an advanced stage of development, and they are eligible for the relevant tax benefits in the U.S.

The agreements establish mechanisms to protect against exposure to changes in U.S. import tariffs. Among other things, they establish a mechanism for adjusting the purchase price or refunding amounts to the project companies if certain tariffs are imposed, up to a ceiling stipulated in the agreements.

The agreements include additional terms, including payment in installments in accordance with the projects’ progress, warranties covering defects and panel output, and compensation in the event of a delay in delivery. The project companies will be able to cancel the agreements in the event of force majeure that delays the parties’ performance of their obligations for at least 90 days. In addition, the agreements provide an option to cancel the engagement without specific cause, subject to payment of compensation to the supplier.

The company’s shares are up about 2.63% on the TASE.

Finally, the euro is down about 0.16% at NIS 3.41. The dollar is up about 0.2% at NIS 3.05.

Key takeaways

  • The Tel Aviv market opened mixed, with the TA-35 down about 0.69%, the TA-90 up about 0.12%, and the TA-125 down about 0.48%.
  • Bonus BioGroup led the declines, plunging about 34.64%, while Givui Holdings led gains with a jump of about 28.57%.
  • NewMed Energy said the notice canceling the Leviathan gas supply agreement remains in effect because the precedent conditions were not met.
  • Dalia said the agreement has already taken effect and that the cancellation notice is invalid, while the dispute also involves Ratio Energies and the Leviathan reservoir partners.
  • Doral said its U.S. project companies signed three solar panel purchase agreements totaling about $470 million for projects with a combined capacity of about 1.45 gigawatts.

Questions and answers

Why is Bonus BioGroup falling so sharply?
The article says Bonus BioGroup is plunging about 34.64%, but it does not give a specific reason for the move.
What is the dispute over the Leviathan gas agreement?
NewMed Energy says the cancellation notice remains in effect because the conditions precedent were not met. Dalia says the agreement already took effect and that the cancellation notice is invalid.
What did Doral announce today?
Doral said its U.S. project companies signed three agreements to buy solar panels from an international supplier for about $470 million. The panels are for three projects with a combined capacity of about 1.45 gigawatts.

Share this story

About the writer

Alma Tal Tzur

Writes for TV10, Israel’s economic channel. This story was translated from the original Hebrew.

More stories by Alma Tal Tzur

More for you